Daiichi Sankyo Co Ltd 2015 Annual Report with Sustainability Disclosures
Company: Daiichi Sankyo Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2015
Type: Annual Report with Sustainability Disclosures
Pages: 49
The report presents fiscal 2014 as a year of continued pharmaceutical innovation and global expansion, with revenue reaching ¥919.4 billion and edoxaban launched in Japan and the U.S. and approved in Europe. It also reports consolidated ESG data, including 16,428 employees, 172,632 t-CO2 of global Scope 1 emissions including Ranbaxy, and 4,772 1,000 GJ of Group energy use. The report emphasizes responsible corporate activities spanning compliance, employees, stakeholders, environmental management, medical access, and social contribution.
Services
From bulk PDFs to structured indicators and machine-readable documents.